We are live on ! Find out more
MRVI icon

Maravai LifeSciences
MRVI

158 hedge funds and large institutions have $344M invested in Maravai LifeSciences in 2026 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 51 increasing their positions, 52 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more call options, than puts

Call options by funds: $1.29M | Put options by funds: $1.08M

17% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 24

1% less funds holding

Funds holding: 159 → 158 (-1)

2% less repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 52

6.28% less ownership

Funds ownership: 89.23% → 82.95% (-6.3%)

18% less capital invested

Capital invested by funds: $421M → $344M (-$77.2M)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
158
Holders Change
-1
Holders Change %
-0.63%
% of All Funds
1.94%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.05%
New
28
Increased
51
Reduced
52
Closed
24
Calls
$1.29M
Puts
$1.08M
Net Calls
+$207K
Net Calls Change
-$3.15M

Top Buyers

1
B
Braidwell
Connecticut
+$6.4M
2
Citadel Advisors
Citadel Advisors
Florida
+$2.94M
3
Two Sigma Investments
Two Sigma Investments
New York
+$2.49M
4
First Eagle Investment Management
First Eagle Investment Management
New York
+$2.46M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.89M

Top Sellers

1
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$18.1M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$7.67M
3
MFS
Mirabella Financial Services
United Kingdom
-$6.86M
4
1WCM
12 West Capital Management
New York
-$5.63M
5
EP
Eversept Partners
New York
-$2.34M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$3.14M +$780K +230,053 +26%
T. Rowe Price Investment Management
27
T. Rowe Price Investment Management
Maryland
$2.83M -$18.1M -5,336,680 -84%
Charles Schwab
28
Charles Schwab
California
$2.81M +$18K +5,308 +0.5%
VPM
29
Vanguard Portfolio Management
Pennsylvania
$2.7M +$3.23M +952,838 New
FPA
30
First Pacific Advisors
California
$2.5M – – –
Deutsche Bank
31
Deutsche Bank
Germany
$2.43M +$36.4K +10,724 +1%
Lazard Asset Management
32
Lazard Asset Management
New York
$2.4M -$579K -170,919 -17%
VFT
33
Vanguard Fiduciary Trust
Pennsylvania
$2.19M +$2.63M +774,576 New
BMS
34
Brummer Multi-Strategy
Sweden
$2.15M +$1.02M +302,036 +66%
Bank of America
35
Bank of America
North Carolina
$1.65M -$405K -119,503 -17%
Citigroup
36
Citigroup
New York
$1.37M -$128K -37,806 -7%
Cerity Partners
37
Cerity Partners
New York
$1.33M +$4.83K +1,426 +0.3%
Jacobs Levy Equity Management
38
Jacobs Levy Equity Management
New Jersey
$1.3M +$1.01M +297,809 +185%
Tudor Investment Corp
39
Tudor Investment Corp
Connecticut
$1.12M +$1.35M +396,915 New
JP Morgan Chase
40
JP Morgan Chase
New York
$1.03M -$227K -67,046 -16%
SI
41
Symmetry Investments
Jersey
$1.02M +$341K +100,528 +39%
Invesco
42
Invesco
Georgia
$995K +$19.6K +5,785 +2%
Bank of New York Mellon
43
Bank of New York Mellon
New York
$973K +$30.4K +8,955 +3%
CFM
44
Capricorn Fund Managers
United Kingdom
$961K +$1.15M +339,727 New
DIM
45
Delta Investment Management
California
$870K -$367K -108,229 -26%
Creative Planning
46
Creative Planning
Kansas
$809K +$209K +61,504 +27%
QOP
47
Quinn Opportunity Partners
Virginia
$750K – – –
N
48
Nuveen
North Carolina
$651K +$4.93K +1,454 +0.6%
SPS
49
Susquehanna Portfolio Strategies
Pennsylvania
$647K -$25.7K -7,588 -3%
PCM
50
PenderFund Capital Management
British Columbia, Canada
$580K -$52.5K -15,500 -7%
1
2
3 4 5

MRVI Hedge Fund Activity: Q1 2026 in Review

158 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Maravai LifeSciences (MRVI) for Q1 2026, worth a combined $344M — down 18% from $421M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new MRVI positions and 24 closed out — a net gain of 4 holders — while 51 added to existing stakes and 52 trimmed.

The largest buyer was Braidwell, adding an estimated $6.4M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $18.1M.

  • 158 institutional investors held Maravai LifeSciences (MRVI) as of Q1 2026, down from 159 in Q4 2025.
  • Funds reported $344M of Maravai LifeSciences stock for Q1 2026, down 18% quarter-over-quarter.
  • 28 funds opened new Maravai LifeSciences positions in Q1 2026 and 24 closed out, a net change of +4 holders.
  • The largest Maravai LifeSciences buyer in Q1 2026 was Braidwell, an estimated $6.4M added.
  • The largest Maravai LifeSciences seller in Q1 2026 was T. Rowe Price Investment Management, an estimated $18.1M sold.

Based on aggregated 13F filings for Q1 2026.